Senti Biosciences, Inc.
Datakwaliteit: 100%
SNTI
Nasdaq
Manufacturing
Chemicals
€ 0,87
▲
€ 0,00
(0,37%)
Marktkapitalisatie: 26,82 M
Prijs
€ 0,86
Marktkapitalisatie
26,82 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Negative free cash flow of -43,64 M
Capital intensive — 890,91% of revenue goes to capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-374,93%
Onder sectorgemiddelde (-53,41%)
ROIC-109,54%
Net Margin-279263,64%
Op. Margin-312631,82%
Veiligheid
Debt / Equity
N/A
Current Ratio1,51
Interest CoverageN/A
Waardering
PE (TTM)
-0,44
Boven sectorgemiddelde (-1,48)
P/B Ratio3,30
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,4 | -1,5 |
| P/B | 3,3 | 1,6 |
| ROE % | -374,9 | -53,4 |
| Net Margin % | -279263,6 | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | -90,73% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 22.000,0 | Net Income (TTM) | -61,44 M |
| ROE | -374,93% | ROA | -101,36% |
| Gross Margin | N/A | Operating Margin | -312631,82% |
| Net Margin | -279263,64% | Free Cash Flow (TTM) | -43,64 M |
| ROIC | -109,54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,51 |
| Interest Coverage | N/A | Asset Turnover | 0,00 |
| Working Capital | 6,13 M | Tangible Book Value | 8,12 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,44 | Forward P/E | N/A |
| P/B Ratio | 3,30 | P/S Ratio | 1218,88 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -162,74% | ||
| Market Cap | 26,82 M | Enterprise Value | 14,57 M |
| Per Share | |||
| EPS (Diluted TTM) | -2,73 | Revenue / Share | 0,00 |
| FCF / Share | -1,40 | OCF / Share | -1,39 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 890,91% | FCF Conversion | 71,03% |
| SBC-Adj. FCF | -48,59 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 22.000,0 | 0,0 | 2,56 M | — | 4,29 M |
| Net Income | -61,44 M | -52,79 M | -71,06 M | -3,86 M | -58,21 M |
| EPS (Diluted) | -2,73 | -12,03 | -1,60 | — | -2,23 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -68,78 M | -61,04 M | -92,73 M | -3,87 M | -70,63 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 37,59 M | 34,36 M | 32,15 M | — | 34,07 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0,0 | — | — | 0,0 | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Total Assets | 51,22 M | 97,84 M | 119,48 M | 231,46 M | 180,79 M |
| Total Liabilities | 45,63 M | 47,09 M | 52,57 M | 10,33 M | 53,53 M |
| Shareholders' Equity | 5,59 M | 25,65 M | 66,91 M | -8,88 M | 127,26 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 16,42 M | 48,28 M | 35,93 M | 889.323,0 | 57,62 M |
| Current Assets | 23,27 M | 58,96 M | 71,20 M | 1,30 M | 102,58 M |
| Current Liabilities | 13,97 M | 13,15 M | 12,67 M | 3,28 M | 18,05 M |
{"event":"ticker_viewed","properties":{"ticker":"SNTI","listing_kind":"stock","pathname":"/stocks/snti","exchange":"Nasdaq","country":"US"}}